Mengxi Huang

1.0k citations
31 papers · 655 indexed · h-index 15
Topics
MicroRNA in disease regulation (4 papers)RNA modifications and cancer (4 papers)Ubiquitin and proteasome pathways (3 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaCancer Research

In The Last Decade

Mengxi Huang

28 papers receiving 645 citations

Peers

Mengxi Huang
Comparison fields: 5 of 70
  • Molecular Biology 428
  • Cancer Research 195
  • Oncology 169
  • Pulmonary and Respiratory Medicine 90
  • Pathology and Forensic Medicine 66
Replace Shuai Xiao with:
Shuai Xiao China
Marissa Shrader United States
Djamila Ouaret United Kingdom
Jianling Zou China
Domenico Albino Switzerland
Yingqiu Y. Liu United States
Juehui Liu United States
Jay Patrick Lopez United States
Chun-Cai Gu China
Mengxi Huang relative to Shuai Xiao China Shuai Xiao's profile →
Citations per field
00.5×1.5×2.3×
Shuai Xiao · 1×
Citations per year

Countries citing papers authored by Mengxi Huang

Since Specialization
Citations

This map shows the geographic impact of Mengxi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxi Huang more than expected).

Fields of papers citing papers by Mengxi Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxi Huang. The network helps show where Mengxi Huang may publish in the future.

Co-authorship network of co-authors of Mengxi Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxi Huang. A scholar is included among the top collaborators of Mengxi Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxi Huang. Mengxi Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 2
4 4
5 1
6 1
7 47
8 38
9 8
10 40
11 4
12 3
13 25
14 14
15 11
16 60
17 15
18 94
19 59
20 76

About Mengxi Huang

Mengxi Huang is a scholar working on Oncology, Cancer Research and Physiology, having authored 31 papers that have together received 655 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (195 citations), Molecular Biology (428 citations) and Oncology (169 citations). Mengxi Huang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoyuan Chu, Zengjie Lei, Dong Han, Liya Wang, Yanyan Chen, Cheng Chen, Ye Wang, Cheng Chen, Tao Xie and Tao Xie. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026